nondermatoxic hydrocarbons on the epidermal penetration of hexadecane. The results of these studies are reported in this publication.
METHODS
Male albino guinea pigs were used as test animals in these experiments. The hair was clipped from the back of the animals and the C-14-labeled test material applied to a 20 cm2 area. After 48 hours the animals were sacrificed and the residual test material removed from the skin surface by wiping with chloroform-saturated cloths. The epidermis from the treated area was separated from the dermis by the stretch method (4) . The dermis thus exposed was thoroughly wiped with a chloroform-saturated cloth. The dermis and subdermal muscle underlying the treated area were collected as well as the kidneys and liver. Epidermis, dermis, kidney, and liver were extracted using the chloroform-methanol procedure of Bligh and Dyer (5) . The chloroform was removed from the extracts under reduced pressure. The resulting residue was dissolved in toluene and an aliquot added to 10 ml of scintillation fluid (5.0 gin 2,5-diphenyloxazole (PPO) and 0.3 gui 1,4-bis-2-5-phenyloxazolyl-benzene (POPOP) per liter of toluene) and the volume adjusted with toluene to 15 ml. Samples of dried subdermal muscle and blood were cornbusted in an oxygen combustion apparatus, the CO2 trapped in ethanolamine-methylcellosolve, and an aliquot added to a scintillation medium containing 5.5 gm PPO per liter of solvent (toluene : methyl cellosolve 3:2 v/v) (6). The radioactivity determinations were made using a TriCarb Liquid Scintillation Spectrometer with a maximum statistical counting error of less than 5%. Appropriate background subtractions were made using preparations from control animals not treated with radioactive materials. Quenching corrections were calculated by the use of internal standards.
The experimental treatments were as follows: Experiment 1. Effect of application vehicle on the penetration of hexadecane into and through the epidermis. * Only 2 of the four epidermal samples in each of these two treatment groups were analyzed for C-14. t The mean of group 1 was significantly different (P < .05) from the means of groups 2, 3 and 4; no significant differences (P > .05) were found for the other comparisons.
RESULTS
Forty-eight hours after application up to 20% of the topically applied dose of hexadecane-C-14 was found in the epidermal tissue of the treated area. The procedure used to remove the residual test material from the skin surface was found, by measuring C-14 in repeated wipings, to be effective; therefore, the C-14 present in the epidermal samples represented hexadecane that had penetrated into the epidermis. The dermis underlying the treated area contained a readily measurable 0.1% of the applied dose of C-14 and the liver and kidneys a total of about 0.1%. The blood did not contain measurable amounts of C-14. Experiment 1. Forty-eight hours following topical application more (P < .05) C-14 from hexadecane-1-C-14 was found in the epidermis (Table I ) of animals treated with hexadecane alone than in those treated with an equal amount of hexadecane admixed with heptane, docosane, or mineral oil. It should be noted that some epidermal hyperplasia occurred during the 48 hour treatment period particularly in lots 1 and 3, thus influencing the C-14 content expressed as cpm per gram of fresh epidermis.
However, when the epidermal C-14 content was expressed as a % of applied dose for the entire treated skin area, similar differences between treatment groups were obtained. The highest concentration of C-14 in the dermis (Table II) Experiment . Pre-treatment of the skin with unlabeled hexadecane (Table IV) did not decrease, but appeared to increase, the amount of C-14 taken up by the epidermis from a subsewas also found in the group treated with hexadecane only; admixtures of mineral oil with hexadecane caused the dermis to contain only 40% of that amount (P < .05). The accumulation of C-14 in the dermis was also lowered (P < .05) by adding docosane to hexadecane but was not significantly decreased (P > .05) by adding heptane. Similar treatment effects to those found for dermis were found for C-14 in the subdermal muscle (Table III) mal of group 1 is unexplained. The C-14 contents of kidney and liver were low and no significant difference was found between treatments.
quent application of labeled hexadecane. The mean C-14 content of the epidermis was about 50% higher in hexadecane pretreated animals than in those receiving the single application, however, the small number of animals precludes drawing a definite conclusion. Application of hexadecane in mineral oil again resulted in reduced penetration of the labeled alkane; in fact, the protective effect of mineral oil was heightened by pre-treatment since the amount of C-14 in the epidermis and dermis was only one half that from the corresponding single application (Table IV) .
DISCUSSION
About 20% of the topically applied C-14 (as hexadecane-1-C-14) was taken up by the epidermis at 48 hours, however, the amounts recovered in subepidermal tissues were small. Thus, the epidermis provided a considerable barrier to the penetration of this alkane. The relationship of these findings to the hydrocarbon dermatoxicity problem is difficult to assess because of two unknown factors. The first of these unknowns related to the precise location of the hexadecane within the epidermis (cornified vs.
vital layers) and the second to the site or mechanism of action of the hydrocarbon in inducing tissue proliferation.
The most pertinent findings from these experiments which bears on these questions were that simultaneous application of mineral oil, docosane, or heptane with hexadecane all reduced the uptake of hexadecane by the epidermis, however, only mineral oil and docosane reduced the amount of hexadecane which penetrated into the dermis and subdermal muscle. Co-application of docosane or mineral oil with hexadecane also prevents hexadecane-induced hyperplasia and hyperkeratosis whereas heptane is not effective in this regard (3). This correlation provides some evidence that penetration of hexadecane into the dermis is essential for the initiation of its dermatoxic potential. The reduced uptake of hexadecane by the epidermis when applied in a vehicle is possibly a dilution effect. If the epidermis has a finite capacity to absorb hydrocarbons, then equal mixtures of hexadecane : vehicle would be expected to reduce the amount of hexadecane taken up by the epidermis by about 50% assuming that no specific absorption takes place. This was essentially the observed result. In 1964 Huang, Wheeldon, and Thompson reported on the formation of a lipid membrane from a system composed of highly purified phosphatidylcholine and n-tetradecane dissolved in a chloroform-methanol solvent (8) . The mem- 
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* Mean data taken from Table I. brane had similar dimensions to the proposed membrane models (9) and permeability and electrical properties compatible with a membrane composed of lipid, hydrocarbon, and water. Treherne measured the penetration of several radioactive materials through excised rabbit skin and calculated permeability constants for these materials (10) . The data showed agreement with theoretical values for penetration through a lipoid-water-lipoid sandwich. These observations suggest that hydrocarbons and certain other organic solvents of a particular size or configuration may be able to fit into the cell membrane matrix and thereby affect the integrity and functional properties of the membrane. This could be a potential mechanism of action for these materials at the cellular level which could be effective at either the epidermal or dermal level.
The experiments measuring the effects of pretreatment upon penetration provides some explanation for the observation that multiple application increases the severity of the response to hexadecane (11) . The observed increase in the level of C-14 in the epidermis of pretreated animals may be a reflection of a reduction in the ability of the epidermis to prevent penetration perhaps as a result of tissue disruption from the earlier applications.
The ability of high-boiling hydrocarbons to prevent the expression of the dermatoxic potential of lower-boiling hydrocarbons apparently can be explained on the basis of their ability to interfere with the penetration of the dermatoxic material. The data herein presented on the effect of vehicle on the accumulation of hexadecane in the dermis and subdermal muscle and the report of Hoekstra and Phfflips (3) on the reduction of hexadecane dermatoxicity by mineral oil coapplication minimize the role of simple dilution in this process.
SUMMARY
The C-14 content of epidermis, dermis, subdermal muscle and certain other tissues was determined 48 hours following topical application of hexadecane-1-C-14 to the skin of guinea pigs. The effect of simultaneous application of U.S.P. heavy mineral oil, n-docosane, and heptane as well as hexadecane pre-treatment on the extent of penetration of hexadecane-1-C-14 was also measured.
Large amounts of C-14 were found in the epidermis whereas relatively little accumulated in the dermis and underlying tissues. Each of the carrier vehicles reduced the amount of C-14 in the epidermis; whereas, docosane and mineral oil, but not heptane, reduced the amount of C-14 in the dermis and subdermal muscle. This correlated with the ability of heavy mineral oil and docosane, but not heptane, to decrease the dermatoxic effects of hexadecane. Pre-treatment of the skin with hexadecane 48 hours prior to application of hexadecane-1-C-14, if anything, increased the amount of the C-14 in the epidermis; however, pre-treatment with mineral oil: hexadecane reduced the amount of epidermal and dermal C-14 from a subsequent application of mineral oil: hexadecane-1-C-14.
The results support the proposal that heavy mineral oil and alkanes with a chain length of over 20 carbon atoms reduce the dermatoxic effect of hexadecane by interfering with its penetration to the site of action. This site would appear to be either the deeper layers of epidermis or possibly the dermis. The increased uptake of hexadecane-C-14 by the epidermis following pretreatment with hexadecane provides a possible explanation for the more severe response seen with multiple hexadecane applications as opposed to a single application of the same amount of material.
